SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

GDR (GDR) News

Track canonical SquawkNews coverage tagged to GDR, GDR. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol GDR Asset equity Sector Markets 90 days 3 Updated Sep 03, 2026, 12:42 PM UTC Open live news feed
L GDR: Rapid pharmacogenetic testing adoption accelerates, with key NHS and international milestones ahead Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in the UK and internationally, with two CE-IVD certified products addressing critical clinical needs. Key milestones include NICE guidance a EARNINGS | Sep 03, 2026, 12:42 PM UTC L GDR: Rapid pharmacogenetic testing adoption accelerates, with national and international scale in sight Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in UK and international markets, with two CE-IVD certified products addressing critical needs in neonatal and stroke care. National adoption EARNINGS | Sep 03, 2026, 11:21 AM UTC L Genedrive PLC director/PDMR notification received Genedrive PLC has filed a director/PDMR notification. EQUITY | Sep 01, 2026, 06:01 AM UTC